Insider Trading History of Welch William J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Welch William J since 2014. The trader's CIK number is 1237522. At the time of the last reporting, Welch William J was the CEO of Cardiff Oncology, Inc.. (stock ticker symbol CRDF). Also see all insider trading activities at Cardiff Oncology, Inc..

Note that in the past WELCH WILLIAM J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Cardiff Oncology, Inc. (TROV) by Welch William J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 TROV 0 $0 0 $0 180,000 $0
2016 TROV 4,750 $9,941 0 $0 0 $0

Yearly summary of insider trading at Sequenom Inc (SQNM) by Welch William J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 SQNM 10,000 $36,500 0 $0 19,000 $0
2014 SQNM 0 $0 0 $0 10,938 $0


Insider trading activities at 2 companies by Welch William J:

1. Cardiff Oncology, Inc. (TROV)

2. Sequenom Inc (SQNM)

Table 1. Insider trading of Cardiff Oncology, Inc. (TROV) by Welch William J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-01-30 TROV Option Ex 130,000 .00 0
2018-01-02 TROV Option Ex 50,000 .00 0
2016-12-16 TROV Buy 4,750 2.09 9,941

Table 2. Insider trading of Sequenom Inc (SQNM) by Welch William J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-06-10 SQNM Option Ex 5,500 .00 0
2015-03-10 SQNM Buy 10,000 3.65 36,500
2015-02-10 SQNM Option Ex 13,500 .00 0
2014-12-10 SQNM Option Ex 10,938 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Welch William J (CEO of Cardiff Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.